Skip to main content
Premium Trial:

Request an Annual Quote

Patients Choice Laboratories Acquires Texas-Based Infectious Disease MDx Lab

NEW YORK — Patients Choice Laboratories (PCL) said on Tuesday that it has acquired Infinity Laboratories, a Texas-based infectious disease lab specializing in molecular diagnostics.

Financial and other terms of the deal were not disclosed.

According to Indianapolis-based PCL, the acquisition will provide it with a location in the southern US. The company said it will begin running tests out of the lab in the coming weeks.

"Having already performed laboratory services for Texans for many years, we are looking forward to teaming up with the Texas healthcare community as a local laboratory," PCL President Brad Moss said in a statement. "Our plan is to introduce our complete suite of services to area providers so that they can work with one laboratory to service all their diagnostics needs."

PCL said it specializes in infectious disease, pharmacogenetics, blood work, and toxicology.

In late 2020, PCL received Emergency Use Authorization from the US Food and Drug Administration for a SARS-CoV-2 assay based on a Thermo Fisher test.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.